Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 17, No 1 (2021) Lipid Clinic is an Efficacious Model of Preventive Medicine Abstract  PDF (Eng)  similar documents
A. V. Blokhina, A. I. Ershova, A. N. Meshkov, A. S. Limonova, V. I. Mikhailina, O. M. Drapkina
"... CVR. High or very high CVR individuals revisited the lipid clinic more often than people with lower ..."
 
Vol 17, No 6 (2021) PCSK9 Inhibitors in Clinical Practice: Experience of a Specialized Lipid Center Abstract  similar documents
A. V. Blokhina, A. I. Ershova, A. S. Limonova, O. V. Kopylova, A. N. Meshkov, O. M. Drapkina
"... records of patients who visited the Lipid clinic of the National Medical Research Center for Therapy ..."
 
Vol 11, No 5 (2015) Three-year dynamics and unsolved problems of lipid-lowering therapy Abstract  similar documents
V. A. Sergeeva
"... in 2014) who were treated in the cardiology clinic were examined. Patient survey on the lipid-lowering ..."
 
Vol 11, No 5 (2015) Assessment of lipid profile when using lipid-lowering therapy (statins) in patients with coronary atherosclerosis Abstract  similar documents
N. E. Gavrilova, V. A. Metelskaya, E. B. Yarovaya, N. V. Gomyranova, S. A. Boytsov
"... Aim. To assess of lipid-lowering therapy with statins in very high cardiovascular risk patients ..."
 
Vol 21, No 1 (2025) Impact of hyperlipoproteinemia(a) on the diagnosis of familial hypercholesterolemia and cardiovascular risk assessment Abstract  similar documents
A. M. Namitokov, U. V. Chubykina, V. K. Zafiraki, M. V. Ezhov
"... ≥180 mg/dL. The diagnosis of heterozygous FH was confirmed using the Dutch Lipid Clinic Network (DLCN ..."
 
Vol 9, No 5 (2013) LIPID METABOLISM CORRECTION BY ANTISENSE TECHNOLOGY Abstract  similar documents
O. I. Afanasieva, S. N. Pokrovsky
"... Antisense oligonucleotides (ASO) technology in elaboration of drugs for lipid metabolism ..."
 
Vol 13, No 5 (2017) AGE AND GENDER PECULIARITIES OF BLOOD LIPIDS IN URBAN RESIDENTS (CROSS-SECTIONAL STUDY RESULTS) Abstract  similar documents
S. A. Urazgildeeva, M. Yu. Nizhegorodcev, P. S. Sadovnikov, A. Yu. Olkhovik, D. Yu. Nokhrin, M. V. Muzalevskaya, I. V. Shugurova, D. G. Malenkovskaya, A. V. Tregubov, V. S. Gurevich
"... Aim. To analyze the results of measurements of the blood lipid spectrum of urban  residents ..."
 
Vol 16, No 5 (2020) Pharmacoeconomic Analysis of Therapy with Generic Statin Drugs in Patients with High and Very High Cardiovascular Risk (According to the Study PRIORITY) Abstract  similar documents
S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko
"... with high and very high cardiovascular risk (CVR) in real clinical practice based on the data of the study ..."
 
Vol 6, No 4 (2010) EFFECTS OF ACUTE PHYSICAL EXERCISE OF VARYING INTENSITY ON LIPID METABOLISM IN MIDDLE AGED MEN Abstract  similar documents
G. E. Roytberg, I. D. Slastnikova, O. Ju. Dmitrieva, T. I. Ushakova
"... Aim. To investigate effects of acute physical exercise of varying intensity on lipid metabolism ..."
 
Vol 3, No 3 (2007) THE ASSESSMENT OF EFFECTS OF COMBINED THERAPY WITH MILDRONATE ON LIPID PROFILE, INFLAMMATORY FACTORS AND ENDOTHELIUM FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE Abstract  similar documents
I. V. Sergienko, V. V. Kukharchuk, S. A. Gabrusenko, V. V. Malakhov, V. P. Masenko, M. I. Tripoten, T. V. Balahonova
"... Aim. To study the effect of treatment with metabolic corrector mildronate on lipid profile ..."
 
Vol 17, No 6 (2021) Unsolved Issues of Atherosclerosis Prevention and of Adequate Lipid-lowering Therapy in Patients with Acute Ischemic Cerebrovascular Accident Abstract  similar documents
S. A. Boytsov, M. A. Piradov, M. M. Tanashyan, I. A. Voznjouk, M. V. Ezhov, E. V. Oschepkova, I. V. Sergienko, N. A. Shamalov, S. N. Yanishevskiy
"... of atherothrombotic genesis, namely lipid metabolism disorders, the modern evidence base for lipid-lowering therapy ..."
 
Vol 11, No 5 (2015) Changes in serum lipids in patients with rheumatoid arthritis treated with a combination of tocilizumab and methotrexate compared with methotrexate alone for 24 weeks of observation Abstract  similar documents
E. V. Udachkina, D. S. Novikova, T. V. Popkova, E. Yu. Panasyuk, A. S. Avdeeva, A. V. Volkov, I. G. Kirillova, E. I. Markelova, E. N. Aleksandrova, A. A. Novikov, E. L. Nasonov
"... arthritis (RA) is accompanied by deterioration of blood lipid profile. Aim. To study changes in serum lipid ..."
 
Vol 20, No 4 (2024) Increased lipoprotein (a) as an additional factor in the failure to achieve target blood pressure levels and lipid spectrum optimal parameters in patients with arterial hypertension and multifocal atherosclerosis Abstract  similar documents
S. S. Vedenskaya, O. G. Smolenskaya
"... Aim. To establish the frequency of achieving target of blood pressure (BP) levels and lipid ..."
 
Vol 2, No 2 (2006) THE WAYS OF SYMPATHETIC SYSTEM OVERACTIVITY BLOCKING: RILMENIDINE VERSUS ATENOLOL Abstract  similar documents
Y. R. Kasherininov, E. K. Shavarova, A. A. Shavarov, N. V. Vachrameeva, A. N. Krutikov, E. V. Smirnova, A. O. Коnrady, E. V. Shlyakhto
"... Aim. To evaluate effects of long-term treatment with rilmenidine compared with atenolol on lipid ..."
 
Vol 20, No 2 (2024) Comparative placebo-controlled study on the effect of dietary supplements containing omega-3 polyunsaturated fatty acids on hemodynamics and lipid metabolism in postmenopausal women Abstract  similar documents
D. A. Napalkov, A. A. Sokolova, A. A. Kudrjavtseva, A. I. Skripka, A. V. Zhilenko, E. V. Kolpachkova, D. K. Varvarina
"... electrocardiogram (HM-ECG), and lipid profile in postmenopausal women. Material and methods. The study involved 95 ..."
 
Vol 20, No 5 (2024) Russian extreme hypertriglyceridemia registy (REGGI): a call to action Abstract  similar documents
U. V. Chubykina, M. V. Ezhov, A. A. Sokolov, P. A. Vasiluev, O. N. Ivanova, E. Y. Zakharova
 
Vol 18, No 4 (2022) Non-High Density Lipoprotein Cholesterol: A Modern Benchmark for Assessing Lipid Metabolism Disorders Abstract  PDF (Eng)  similar documents
S. A. Shalnova, V. A. Metelskaya, V. A. Kutsenko, E. B. Yarovaya, A. V. Kapustina, G. A. Muromtseva, G. E. Svinin, Yu. A. Balanova, A. E. Imaeva, S. E. Evstifeeva, V. G. Vilkov, O. L. Barbarash, O. A. Belova, Yu. I. Grinshtein, A. Yu. Efanov, O. N. Kalachikova, N. V. Kulakova, O. P. Rotar, I. A. Trubacheva, D. V. Duplyakov, R. A. Libis, I. A. Viktorova, A. N. Redko, S. S. Yakushin, S. A. Boytsov, E. V. Shlyakhto, O. M. Drapkina
"... in ESSE RF (1) and 3.8 years in ESSE RF(2). Analysis was performed for three lipid variables: total ..."
 
Vol 18, No 3 (2022) Lipid profile of patients with arterial hypertension who underwent COVID-19: possibilities of drug therapy/ LEADER Abstract  similar documents
I. A. Zolotovskaya, V. P. Kuzmin, O. A. Rubanenko, P. R. Shatskaya, A. S. Salasyuk
"... Aim. To study the dynamics of the lipid profile of hypertensive patients with dyslipidemia who ..."
 
Vol 15, No 4 (2019) The Association of Smoking Status and Intensity of Smoking with Blood Lipid Spectrum in a Sample of Middle-Aged Men Abstract  similar documents
A. A. Alexandrov, V. B. Rozanov, M. B. Kotova, V. A. Dadaeva, E. I. Ivanova
"... Цель. Оценить связь курительного статуса и интенсивности курения с нарушениями липидного спектра ..."
 
Vol 17, No 6 (2021) Factors Determining the Three-Year Dynamics of Lipid Metabolism Indicators in Residents of a Large Industrial Region of Siberia Abstract  similar documents
D. P. Tsygankova, E. D. Bazdyrev, E. V. Indukaeva, A. S. Agienko, O. V. Nakhratova, G. V. Artamonova, O. L. Barbarash
"... , hypertension, smoking, alcohol consumption and an increase in the number of respondents taking lipid-lowering ..."
 
Vol 14, No 1 (2018) IDENTIFICATION OF PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA IN THE RUSSIAN POPULATION USING THE EXAMPLE OF MOSCOW CITY AND MOSCOW REGION Abstract  similar documents
I. V. Sergienko, A. A. Ansheles
"... such patients to specialized clinics for more qualified consultations and selection of optimal lipid-lowering ..."
 
Vol 20, No 6 (2024) The impact of clinical decision support systems on adherence to clinical guidelines and achieving target levels of low-density lipoprotein cholesterol in patients at risk of developing cardiovascular events (SuccESS) Abstract  similar documents
K. S. Astrakova (Benimetskaya), I. L. Mikheenko, A. E. Uranov, A. A. Gartung, E. A. Kovalev, A. A. Spiridonov, I. I. Shestova, I. L. Strokolskaya, M. A. Meshkova, L. I. Esev, А. V. Reznik, V. А. Petrakovskaia, A. M. Shangina, Yu. E. Efremova, I. V. Sergienko, M. V. Ezhov, O. L. Barbarash, P. N. Paleev
 
Vol 5, No 6 (2009) INFLUENCE OF ENALAPRIL, DIGOXIN, ATENOLOL AND DILTIAZEM ON LIPID PEROXIDATION IN EXPERIMENTAL MODEL OF COMPLEX METABOLIC DISORDERS Abstract  similar documents
A. A. Usanova, A. A. Aleksandrovsky, A. V. Zorkina, O. M. Kiselеv
"... Aim. To study influence of enalapril, digoxin, atenolol and diltiazem on lipid peroxidation ..."
 
Vol 14, No 2 (2018) MONITORING OF THE EFFICACY AND SAFETY OF HIGH-DOSE ATORVASTATIN IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION Abstract  similar documents
L. I. Salyamova, S. S. Fadeeva, A. V. Golubeva, Yu. A. Tomashevskaya, V. E. Oleynikov
"... Aim. To study the effectiveness of achievement of lipid profile target levels and safety ..."
 
Vol 9, No 2 (2013) MEDICAL SUPERVISION IN SPECIALIZED CENTER AND THE QUALITY OF LIPID-LOWERING THERAPY IN PATIENTS WITH CARDIOVASCULAR DISEASES (ACCORDING TO THE PROFIL REGISTER) Abstract  similar documents
S. Yu. Martsevich, O. V. Gaysenok, S. G. Tripkosh, A. V. Zagrebelnyy, Yu. V. Lukina
"... Aim. To assess the quality of lipid-lowering therapy in high risk patients with cardiovascular ..."
 
Vol 6, No 1 (2010) PECULIARITIES OF PURINE METABOLISM AND LIPID PEROXIDATION IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION Abstract  similar documents
E. V. Horolets, L. A. Haisheva, S. V. Shlyk, L. I. Katelnitskaya
"... Aim. To study purine metabolism and lipid peroxidation in patients with acute myocardial ..."
 
Vol 19, No 2 (2023) Outpatient Practice of Lipid-Lowering Therapy Prescription (According to the ARGO-3 Study) Abstract  similar documents
M. V. Ezhov, N. M. Akhmedzhanov, T. E. Kolmakova, A. V. Tyurina, A. I. Martynov
"... Aim. To study the frequency of prescriptions of various types of lipid-lowering therapy ..."
 
Vol 12, No 2 (2016) LIPID-LOWERING THERAPY IN OUTPATIENT PRACTICE (ACCORDING TO THE ARGO-2 STUDY) Abstract  similar documents
N. M. Akhmedzhanov, D. V. Nebieridze, A. S. Safaryan, V. A. Vygodin, A. Yu. Shuraev, A. N. Tkacheva, A. S. Lishuta
"... Aim. To study the features of lipid-lowering therapy with rosuvastatin in high and very high ..."
 
Vol 10, No 5 (2014) EFFICACY OF ROSUVASTATIN IN DYSLIPIDEMIA CORRECTION IN PATIENTS AFTER Q-WAVE MYOCARDIAL INFARCTION Abstract  similar documents
R. D. Kurbanov, N. U. Zakirov, Y. G. Kevorkova, N. B. Sayfiddinova
"... into the study after 10-14 days of the acute Q-MI onset. Determination of blood lipids profile, alanine ..."
 
Vol 1, No 2 (2005) ANTIHYPERTENSIVE, ORGAN PROTECTIVE, AND METABOLIC EFFICIENCY OF SPIRAPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION Abstract  similar documents
M. V. Leonova, M. A. Demidova, A. V. Tarasov, Y. V. Belousov
"... , microalbuminuria and β2-microglobulinuria levels were defined, figures of lipid and glucose metabolism were studied ..."
 
Vol 2, No 3 (2006) EFFECT OF CYTOPROTECTION ON THE OXIDATIVE PROCESSES AND ENDOTHELIAL FUNCTION IN ELDERLY PATIENTS WITH ISCHEMIC HEART DISEASE Abstract  similar documents
A. V. Shabalin, Yu. I. Ragino, S. A. Lyubimtseva, Ya. V. Polonskaya, M. V. Ivanova
"... in LDL), initial level of lipid peroxidation (LPO) products in LDL, LDL resistance to oxidation and blood ..."
 
Vol 5, No 1 (2009) SAFARI - RANDOMISED TRIAL ON COMPLEX THERAPY OF ARTERIAL HYPERTENSION AND DISLIPIDEMY. THE MAIN RESULTS Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko, V. V. Yakusevich, A. D. Deev, A. A. Serazhim, T. V. Bobkova, L. P. Volkonskaya, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, J. V. Lukina, M. A. Maksimova, A. A. Serazhim, S. N. Tolpygina, E. V. Shilova
"... by doctors of out-patient clinics. The study duration was 12 weeks. Results. Systolic and diastolic blood ..."
 
Vol 18, No 1 (2022) Challenges of Statin Therapy in Clinical Practice (According to Outpatient Register «PROFILE» Data) Abstract  PDF (Eng)  similar documents
S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, A. V. Zagrebelnyy, S. N. Tolpygina, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, E. S. Nekoshnova, I. V. Budaeva, S. V. Blagodatskikh, B. B. Aslanova
"... times more often achieved in patients with high CVR, compared with patients with very high CV risk ..."
 
Vol 10, No 5 (2014) DIFFERENTIAL DIAGNOSIS OF HEREDITARY SYNDROME OF HYPOCHOLESTEROLEMIA BY USING EXOMIC SEQUENCING Abstract  similar documents
A. I. Yershova, N. V. Shcherbakova, A. A. Suvorova, E. Y. Hlebus, I. V. Sidonets, A. N. Meshkov, S. A. Boytsov
"... Clinical case study is described. Patient D, 55 years old, applied to the Lipid clinic of State ..."
 
Vol 14, No 1 (2018) THIRTY-YEAR CHANGES IN AVERAGE BLOOD LIPIDS LEVELS IN POPULATIONS OF THE RUSSIAN FEDERATION AND THE USA Abstract  PDF (Eng)  similar documents
S. A. Shalnova, V. G. Vilkov, V. A. Metelskaya, Yu. A. Balanova, A. V. Kapustina
"...  Aim. To conduct a comparative study of the changes in blood lipids profiles in populations ..."
 
Vol 12, No 6 (2016) THE EFFECTIVENESS OF OUTPATIENT AND HOSPITAL LIPID-LOWERING THERAPY IN PATIENTS WITH HIGH AND VERY HIGH CARDIOVASCULAR RISK DURING 2011-2015 Abstract  PDF (Eng)  PDF (Eng)  similar documents
S. A. Smetnev, A. I. Ershova, R. S. Bogdanova, A. N. Meshkov, S. A. Boytsov
"... Aim. To estimate the effectiveness of lipid-lowering therapy (LLT) at outpatient and hospital ..."
 
Vol 6, No 4 (2010) ECONOMIC EFFICIENCY OF THE IMPLEMENTATION OF THE PROGRAM OF CARDIOVASCULAR DISEASES MULTIFACTORIAL PREVENTION IN THE ORGANIZED COLLECTIVE OF TECHNICAL RESEARCH INSTITUTE Abstract  similar documents
A. V. Kontsevaya, A. M. Kalinina, S. V. Belonosova, J. M. Pozdnjakov, M. B. Khudyakov
"... to cardiovascular risk (CVR) decrease was reached due to preventive intervention. Costs associated ..."
 
Vol 2, No 3 (2006) NEW EVIDENCES OF POSSIBILITY OF OMEGA-3 ACIDS USE FOR MYOCARDIAL INFARCTION SECONDARY PREVENTION Abstract  similar documents
A. I. Martinov, V. L. Chomenko
"... and normalization of plasma lipid profile. Omega-3 PUFAs in large dozes show antiatherosclerotic effect. Clinical ..."
 
Vol 16, No 2 (2020) Infectious Endocarditis in the Elderly – Comparative Study of Clinical Features, Course and Outcomes Abstract  PDF (Eng)  similar documents
N. S. Chipigina, N. Yu. Karpova, D. A. Anichkov, T. B. Kondratieva
 
Vol 11, No 6 (2015) Analysis of the problem of low adherence of patients to attendance at outpatient clinics and cardiorehabilitation programs according to the data from published studies Abstract  similar documents
Yu. V. Semenova, N. P. Kutishenko, S. Yu. Martsevich
"... the problem of non-attendance at outpatient clinics and cardiac rehabilitation programs, were used as data ..."
 
Vol 8, No 2 (2012) IMIDAZOLINE RECEPTOR AGONISTS: DO WE KNOW EVERYTHING ABOUT THEIR CAPABILITIES? Abstract  similar documents
D. V. Nebieridze, T. V. Kamyshova
"... , endothelial dysfunction, lipid profile, and plasma fibrinolytic activity are considered. ..."
 
Vol 17, No 1 (2021) Bicuspid Aortic Valve: Morphology, Clinic, Diagnosis, Complications Abstract  similar documents
Y. L. Trysvetava
 
Vol 13, No 1 (2017) VARIABILITY IN LEVELS OF LOW-DENSITY LIPOPROTEINS CHOLESTEROL IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA DEPENDING ON AGE AND SEX AND ITS IMPORTANCE IN THE DIAGNOSIS OF THIS DISEASE Abstract  similar documents
V. А. Korneva, T. Yu. Kuznetsova, G. P. Tihova
"... of FHC was established according to the criteria of The Dutch Lipid Clinic Network.  Genetic analysis ..."
 
Vol 13, No 5 (2017) IS IT POSSIBLE TO IMPROVE THE ADHERENCE TO TREATMENT OF HYPERTENSION AND DYSLIPIDEMIA IN PATIENTS WITHOUT CLINICAL MANIFESTATIONS OF ATHEROSCLEROSIS? Abstract  similar documents
A. А. Sarycheva, D. V. Nebieridze, T. V. Kamyshova
"... doctor  (departmental clinic of Moscow) were examined. The study included only patients (n=150) with high ..."
 
Vol 13, No 3 (2017) INFLUENCE OF PATIENTS’ PREHOSPITAL ATTENDANCE AT OUTPATIENT CLINICS ON LONG-TERM OUTCOMES OF ACUTE CORONARY SYNDROME: LIS-3 STUDY Abstract  similar documents
Yu. V. Semenova, N. P. Kutishenko, A. V. Zagrebelnyy, M. L. Ginzburg, A. D. Deev, S. Yu. Martsevich
"... Aim. To assess influence of patients’ prehospital attendance at outpatient clinics on long-term ..."
 
Vol 14, No 4 (2018) Hospital Stage of Myocardial Infarction Treatment in 13 Regions of Russian Federation by Results of the International Research Abstract  PDF (Eng)  similar documents
A. V. Kontsevaya, K. Bates, E. A. Goryachkin, N. Bobrova, L. I. Syromiatnikova, Yu. V. Popova, D. Yu. Platonov, I. V. Osipova, A. M. Nedbaikin, T. N. Malorodova, O. A. Mirolyubova, D. V. Kryuchkov, L. A. Khaisheva, A. S. Galyavich, M. V. Franz, A. Yu. Efanov, D. V. Duplyakov, O. M. Drapkina, D. Leon, M. McKee
"... and to characterize the main diagnostic and treatment interventions in clinic. Material and methods. This study ..."
 
Vol 17, No 5 (2021) Director of the Faculty Therapeutic Clinic Nikolay Fedorovich Golubov: Scientific Activity, Last Years of Life and Finding of the Lost Grave (by the 165th Anniversary from Birthday) Abstract  similar documents
Y. A. Lutokhina, O. V. Blagova, A. I. Zaitseva, A. V. Nedostup
"... September, 2021 marks the 175th anniversary of the opening of the Faculty Therapeutic Clinic (FTC ..."
 
Vol 12, No 3 (2016) EFFICACY AND SAFETY OF LIPID-LOWERING DRUGS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES IN THE ELDERLY Abstract  PDF (Eng)  similar documents
E. A. Ushkalova, O. N. Tkacheva, N. K. Runikhina, N. A. Chukhareva, A. Yu. Bevz
"... cover issues of efficacy and safety of lipid-lowering therapy in primary and secondary prevention ..."
 
Vol 10, No 5 (2014) RATIONAL APPROACHES TO THE TREATMENT OF DYSLIPIDEMIA WITH DIFFERENT TOTAL CARDIOVASCULAR RISK AND ACUTE CORONARY SYNDROME Abstract  similar documents
N. V. Perova, V. A. Metelskaya
"... of dyslipidemia correction. The use of statins as lipid-lowering therapy in patients with acute coronary syndrome ..."
 
Vol 7, No 1 (2011) DYSLIPIDEMIA FEATURES IN CHILDREN Abstract  similar documents
T. I. Turkinа, M. Yu. Shcherbakova
"... Contemporary scientific and practical data about various lipid metabolism disorders (dyslipidemia ..."
 
Vol 2, No 1 (2006) DEGENERATIVE AORTIC STENOSIS: PATHOGENESIS AND NEW PRINCIPLES OF TREATMENT Abstract  similar documents
O. V. Andropova, V. N. Anokhin
"... computed tomography. Markers of inflammation and lipid profile were investigated.    Results. Higher blood ..."
 
Vol 3, No 5 (2007) BISOPROLOL AND METFORMIN IN PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC SYNDROME Abstract  similar documents
V. A. Nevzorova, N. V. Zakcharchuk, O. V. Nastradin, O. G. Pomogalova
"... and metformin. Blood pressure (BP), body mass index (BMI), carbohydrate metabolism, lipid profile ..."
 
Vol 8, No 5 (2012) LIPID-LOWERING EFFICACY OF ROSUVASTATIN COMPARED WITH OTHER STATINS Abstract  similar documents
A. N. Meshkov
"... Assessment of lipid-lowering effect of rosuvastatin is presented, as well as the main results ..."
 
Vol 11, No 1 (2015) PHARMACOEPIDEMIOLOGY AND THE EFFICACY OF ANTIHYPERTENSIVE TREATMENT IN REAL-LIFE PRACTICE OF THE CARDIOLOGY REFERRAL CLINIC Abstract  similar documents
A. V. Kontsevaya, T. S. Romanenko, V. A. Vygodin, S. B. Fitilev
"... the cardiology referral clinic for the first time and to assess treatment dynamics over the following 6 months ..."
 
Vol 4, No 4 (2008) COMPARISON OF DIFFERENT STRATEGIES OF ANTIHYPERTENSIVE THERAPY IN OUT-PATIENT CLINIC Abstract  similar documents
O. A. Plejko, A. O. Konradi
 
Vol 9, No 5 (2013) THE ROLE OF LIPOTROPIC THERAPY IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE BEFORE AND AFTER CORONARY REVASCULARIZATION Abstract  similar documents
R. N. Adzhiev, M. S. Safarova, M. V. Ezhov
"... Review of large of trials that prove the positive impact of high-dose lipid-lowering therapy ..."
 
Vol 14, No 5 (2018) Economic losses due to low coverage of lipid-lowering therapy in patients with cardiovascular diseases in the Russian Federation Abstract  similar documents
Yu. A. Balanova, A. V. Kontsevaya, A. E. Imaeva, O. I. Karpov, M. B. Khudyakov
"... Aim. To assess the economic burden associated with the absence of lipid-lowering therapy (LLT ..."
 
Vol 12, No 4 (2016) Adherence to attendance at outpatient clinic, quality of prehospital therapy, and direct outcome of acute coronary syndrome: analysis within LIS-3 registry Abstract  similar documents
Yu. V. Semenova, N. P. Kutishenko, A. V. Zagebelnyy, A. D. Deev, M. L. Ginzburg, S. Yu. Martsevich
"... Aim. To assess the influence of patients’ adherence to attendance at outpatient clinics (OPC ..."
 
Vol 14, No 1 (2018) PROBLEMS OF EVALUATING BLOOD PRESSURE MEASUREMENT IN MODERN CLINICAL TRIALS (THE CASE OF SPRINT STUDY RESULTS) Abstract  similar documents
V. M. Gorbunov
"... significantly lower BP values, compared to the conventional clinic BP measurement. This article reviews ..."
 
Vol 11, No 4 (2015) THE ATTITUDE TOWARDS TREATMENT OF CARDIOVASCULAR DISEASES: A SURVEY OF PATIENTS OF STATE OUTPATIENT CLINICS AND PRIVATE MEDICAL CENTERS Abstract  similar documents
O. N. Semenova, E. A. Naumova, Yu. G. Shvarts
"... in state and private outpatient clinics, as well as the motivation for choosing one of these outpatient ..."
 
Vol 8, No 1 (2012) PHARMACOECONOMIC EVALUATION OF DABIGATRAN VS WARFARIN IN CARDIOVASCULAR EVENTS PREVENTION IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION Abstract  similar documents
Yu. B. Belousov, V. Yu. Mareev, I. S. Yavelov, D. Yu. Belousov
 
Vol 18, No 1 (2022) Polymorbidity and Polypragmasia in High and Very High Cardiovascular Risk Patients Abstract  similar documents
N. V. Izmozherova, A. A. Popov, A. A. Kuryndina, E. I. Gavrilova, M. A. Shambatov, V. M. Bakhtin
"... , observed in outpatient clinics. Material and methods. The single-stage study included 282 patients of high ..."
 
Vol 7, No 1 (2011) ATHEROSCLEROSIS: HOW TO START UP A "COUNT DOWN" CLOCK? WE DON'T KNOW, WE CAN NOT OR WE DO NOT WANT? Abstract  similar documents
L. N. Malay
"... on the soft end (lipid profile) and hard end (number of heart attacks, strokes, heart failure, hospitalization ..."
 
Vol 4, No 4 (2008) ANTIHYPERTENSIVE EFFICACY OF VERAPAMIL PLUS INDAPAMIDE IN PATIENTS WITH METABOLIC SYNDROME Abstract  similar documents
E. M. Idrisova, T. P. Kalashnikova, E. I. Mananko, E. V. Vorobyeva
"... (Arifon retard) on blood pressure (BP) level as well as lipid profile, glucose and electrolytes serum ..."
 
Vol 2, No 4 (2006) CLINICAL EFFICACY OF MONOTHERAPY WITH INDAPAMIDE IN PATIENTS WITH ARTERIAL HYPERTENSION OF THE I-II DEGREES Abstract  similar documents
E. Yu. Тourkassova, T. G. Volkova, E. M. Idrissova, E. M. Vorobyeva, R. S. Karpov
"... , Russia) and its influence on blood levels of carbohydrates, lipids and electrolytes in patients ..."
 
Vol 8, No 4 (2012) UP TO DATE STATINS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES Abstract  similar documents
N. F. Puchin'yan, Ya. P. Dovgalevskiy, A. V. Panina
"... components according to multifactor origin of cardiovascular disease (CVD). Correction of lipid metabolism ..."
 
Vol 6, No 2 (2010) CHANGE IN BALANCE BETWEEN ACTIVITY OF LIPID PEROXIDATION, ANTIOXIDANT SYSTEM AND FERRUM CONTENT IN RATS WITH EXPERIMENTAL MYOCARDIAL INFARCTION Abstract  similar documents
L. D. Hidirova
"... Aim. To study the balance between activity of lipid peroxidation, antioxidant system and ferrum ..."
 
Vol 3, No 1 (2007) EFFECTS OF METABOLIC DRUG ELTACINE ON CLINICAL, FUNCTIONAL AND BIOCHEMICAL INDICES IN PATIENTS WITH CHRONIC HEART FAILURE Abstract  similar documents
R. M. Zaslavskaya, G. V. Lilitsa, Ye. V. Kalinina, I. A. Komissarova, L. N. Maximova
"... of lipids (POL) and cell anti-oxidant protection were implemented. Results. Eltacine increased in tolerance ..."
 
Vol 14, No 3 (2018) HYPOLIPIDEMIC THERAPY IN STROKE PREVENTION: EXISTING STANDARDS, EVIDENCE-BASED MEDICINE DATA AND REAL PRACTICE Abstract  similar documents
O. V. Gaisenok, A. N. Rozhkov, A. S. Lishuta
"... . The issues of lipid-lowering therapy with statins in the aspect of stroke prevention are discussed ..."
 
Vol 17, No 2 (2021) The Importance of Antihypertensive and Lipid-Lowering Therapy in the Treatment of Patients with a New Coronavirus Infection COVID-19 Abstract  similar documents
V. I. Podzolkov, A. I. Tarzimanova
"... and rosuvastatin is an effective drug that allows achieving not only adequate hypotensive and lipid-lowering ..."
 
Vol 16, No 1 (2020) Alirocumab Administration Experience to Achieve Low Density Lipoprotein Cholesterol Target Levels in Secondary Prevention of Cardiovascular Disease Abstract  similar documents
A. E. Nikitin, E. E. Averin, D. E. Rozhkov, A. V. Sozykin, G. A. Procenko
"... , alirocumab, on lipid levels in patients who receive secondary prevention of cardiovascular diseases (CVD ..."
 
Vol 1, No 3 (2005) PHARMACOLOGICAL CORRECTION OF CEREBRAL BLOOD FLOW DISTURBANCES IN WOMEN WITH ARTERIAL HYPERTENSION IN POSTMENOPAUSE Abstract  similar documents
V. V. Yakusevich, M. E. Mozheiko, N. V. Sudareva, N. E. Semyonova
"... hypertension (AH); to evaluate dynamics of cerebral blood flow parameters and plasma lipid concentrations ..."
 
Vol 17, No 2 (2021) Adherence to Medical Treatment in Elderly Patients with Coronary Artery Disease in the Settings of Primary Outpatient Care Abstract  PDF (Eng)  similar documents
S. K. Zyryanov, S. B. Fitilev, A. V. Vozzhaev, I. I. Shkrebneva, N. N. Shindryaeva, D. A. Klyuev, L. N. Stepanyan, A. M. Lutsenko, A. T. Tsai, A. A. Danilova
"... ) in primary care practice. Material and methods. The study conducted in out-patient clinic of Moscow city ..."
 
Vol 17, No 1 (2021) Comparative Assessment of the Clinical Course, Drug Therapy and Outcomes in Myocardial Infarction without or with Obstructive Coronary Artery Disease Abstract  similar documents
O. A. Fomina, S. S. Yakushin
 
Vol 5, No 3 (2009) HEMODYNAMIC INSIGNIFICANT CAROTID ARTERIES STENOSIS AND RISK OF EMBOLIC STROKE IN PATIENTS WITH ISCHEMIC HEART DISEASE Abstract  similar documents
V. V. Semenova, A. N. Zakirova
"... in all patients as well as lipid spectrum, fibrinogen level and blood D-diameter concentration were ..."
 
Vol 4, No 3 (2008) COMBINED ANTIHYPERTENSIVE THERAPY IN METABOLIC SYNDROME Abstract  similar documents
E. I. Mananko, E. A. Bushkova, E. M. Idrisova, A. I. Vengerovsky
"... on blood pressure (BP), myocardial mass and diastolic function of left ventricular, lipid and carbohydrate ..."
 
Vol 9, No 3 (2013) INFLUENCE OF ACARBOSE ON POSTPRANDIAL DYSMETABOLISM: RESULTS OF AN OPEN-LABEL RANDOMIZED STUDY Abstract  PDF (Eng)  similar documents
A. Ya. Cherniak, I. M. Petrov, I. V. Medvedeva
"... Aim. To evaluate postprandial changes of lipid and glucose profiles, inflammation markers levels ..."
 
Vol 17, No 3 (2021) Adherence to Attendance at Outpatient Clinic and Longterm Survival of Patients after Stroke in Outpatient Setting: the Data of REGION-M Registry Abstract  PDF (Eng)  similar documents
S. Yu. Martsevich, S. N. Tolpygina, M. I. Chernysheva, A. V. Zagrebelny, V. P. Voronina, M. M. Lukyanov, N. P. Kutishenko, N. A. Dmitrieva, O. V. Lerman, Yu. V. Lukina, S. V. Blagodatskikh, E. Yu. Okshina, N. E. Parsadanyan
"... .2% after hospital discharge attended the clinic during the year before the development of reference acute ..."
 
Vol 5, No 5 (2009) INFLUENCE OF THE COMBINED ANTIHYPERTENSIVE THERAPY ON METABOLIC PROFILE AND CEREBRAL BLOOD FLOW IN PATIENTS WITH METABOLIC SYNDROME Abstract  similar documents
E. M. Idrisova, T. P. Kalashnikova, I. Yu. Efimova
"... and lipid metabolism as well as cerebral blood flow in patients with metabolic syndrome (МS) Material ..."
 
Vol 11, No 1 (2015) METABOLIC EFFECTS OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH TYPE 2 DIABETES Abstract  similar documents
M. E. Statsenko, M. V. Derevyanchenko
"... and indapamide on insulin resistance (IR), glucose, lipid and purine metabolism in patients with arterial ..."
 
Vol 8, No 4 (2012) EFFECT OF CARDIOVASCULAR DRUGS ON BONE HEALTH AND THE POSSIBILITY OF THEIR USE FOR THE PREVENTION OF OSTEOPOROSIS Abstract  similar documents
I. A. Skripnikova, K. E. Sobchenko, O, V. Kosmatova, D. V. Nebieridze
"... Widespread use of antihypertensive and lipid-lowering agents in clinical practice determines ..."
 
Vol 7, No 2 (2011) EFFICACY AND SAFETY OF BISOPROLOL IN YOUNG MEN WITH ARTERIAL HYPERTENSION AND OBESITY Abstract  similar documents
A. G. Avtandilov, I. I. Esenova, S. L. Petrosov
"... cardiovascular regulation, lipid and carbohydrate metabolism in young patients with arterial hypertension (HT ..."
 
Vol 6, No 4 (2010) EFFECT OF ANTIHYPERTENSIVE THERAPY ON METABOLIC PROFILE AND ERECTILE FUNCTION IN HYPERTENSIVE MEN WITH HIGH CARDIOVASCULAR RISK: FOCUS ON THE COMBINATION OF LISINOPRIL AND AMLODIPINE Abstract  similar documents
M. N. Mamedov, M. V. Stroeva, M. N. Kovrigina, E. A. Poddubskaya
"... pressure (BP) and heart rate measuring, anthropometric studies, evaluation of the plasma lipid profile ..."
 
Vol 14, No 5 (2018) Short Term Comparison Between Safety and Efficacy of Rosuvastatin 40 mg and Atorvastatin 80 mg in Patients with Acute Coronary Syndrome Abstract  PDF (Eng)  similar documents
Sh. A. Mostafa, Kh. Elrabat, M. Mahrous, M. Kamal
"... weeks of treatment and lipid profile after 3 months. Secondary  outcomes included recurrent myocardial ..."
 
Vol 20, No 6 (2024) Development of dyslipidemia in patients after complex treatment of central nervous system tumors in childhood Abstract  similar documents
A. I. Novikova, M. G. Pavlova, N. A. Potemkina, L. B. Fadeev, M. G. Poltavskaya
"... Aim. To assess the impact of comprehensive anticancer therapy on lipid and hormonal profile ..."
 
Vol 19, No 6 (2023) Aggressive course of atherosclerosis in hyperlipoproteinemia (a): a case series Abstract  similar documents
A. M. Namitokov, V. K, Zaphiraki, E. K. Donets, O. B. Malyarevskaya, K. V. Karabakhtsieva, A. N. Yahutl
"... the practice of two lipid centers in Krasnodar, the diversity of clinical scenarios of atherosclerosis ..."
 
Vol 5, No 3 (2009) ARTERIAL STIFFNESS PARAMETERS IN PATIENTS WITH MODERATE/HIGH CARDIOVASCULAR RISK DURING LISINOPRIL AND SIMVASTATIN TREATMENT Abstract  similar documents
V. N. Isakova, O. G. Garbuzova, E. V. Klinkova, E. V. Bandurko
"... and lipid profiles were assessed before therapy and in 1, 2, 6 and 12 month of the observation. Non-invasive ..."
 
Vol 14, No 5 (2018) Metabolic Syndrome: Development of the Issue, Main Diagnostic Criteria Abstract  similar documents
Yu. N. Belenkov, E. V. Privalova, V. Y. Kaplunova, V. Y. Zektser, N. N. Vinogradova, I. S. Ilgisonis, G. A. Shakaryants, M. V. Kozhevnikova, A. S. Lishuta
"... and lipid metabolism, arterial hypertension, and close pathogenic relationship between these  factors ..."
 
Vol 9, No 4 (2013) EFFECTS OF ATORVASTATIN ON ENDOTHELIAL DYSFUNCTION IN TYPE 2 DIABETIC PATIENTS WITH DIFFERENT DURATION F THE DISEASE Abstract  PDF (Eng)  similar documents
G. A. Batrak, S. E. Miasoedova, O. I. Kelesh
"... and target lipid levels achievement. Material and methods. The total of 161 type 2 diabetic patients ..."
 
Vol 9, No 4 (2013) EFFECT OF SIMVASTATIN ON THE PROGNOSIS AND THE CHANGES OF THE CLINICAL STATUS IN PATIENTS WITH ACUTE ISCHEMIC STROKE. THE RESULTS OF THE 12 MONTH RANDOMIZED, OPEN COMPARATIVE STUDY Abstract  similar documents
V. V. Yakusevich, A. Yu. Malygin, A. V. Kabanov
"... . Follow-up duration was 12 months. The lipid profile, a number of desquamated epithelial cells circulating ..."
 
Vol 12, No 6 (2016) EFFICIENCY OF INFLUENZA VACCINATION IN PATIENTS WITH CIRCULATORY SYSTEM DISEASES UNDER DISPENSARY OBSERVATION IN OUTPATIENT CLINICS: PROSPECTIVE FOLLOW-UP MONITORING DATA Abstract  similar documents
S. A. Boytsov, M. M. Loukianov, E. V. Platonova, V. M. Gorbunov, S. V. Romanchuk, O. A. Nazarova, O. A. Belova, E. A. Kravtsova, P. Ya. Dovgalevsky, N. V. Furman, A. A. Mironova, P. V. Dolotovskaya, A. V. Nekrasov, N. G. Puchkova, M. A. Abramova, E. N. Belova, V. G. Klyashtorny, A. D. Deev
"... diseases diseases (CSD) under 3-year follow-up in outpatient clinics. Methods. The efficiency of influenza ..."
 
Vol 14, No 3 (2018) STUDY OF ADHERENCE TO DRUG THERAPY OF PATIENTS WITH CARDIOVASCULAR DISEASES IN DISTRICT HOSPITAL OF SMALL TOWN IN SARATOV REGION AND IN CARDIOLOGY DEPARTMENT OF UNIVERSITY CLINIC IN SARATOV Abstract  similar documents
Yu. V. Bulaeva, E. A. Naumova, O. N. Semenova
"... %) patients in the university clinic; p<0.05 for university clinic]. Conclusion. The adherence to long-term ..."
 
Vol 15, No 1 (2019) Assessment of Antithrombotic Therapy in Patients with Atrial Fibrillation for 2015-2017 According to the Registry of the Clinic of the Scientific Research Institute of Medical Problems of the North of Krasnoyarsk City Abstract  similar documents
A. A. Tuchkov, N. G. Gogolashvili, R. A. Yaskevich
 
Vol 10, No 3 (2014) NEW METABOLIC INDEX USE POTENTIALITIES IN EVALUATION OF INSULIN RESISTANCE IN CLINICAL PRACTICE Abstract  PDF (Eng)  similar documents
G. E. Roytberg, J. V. Dorosh, O. O. Sharkhun, T. I. Ushakova, E. A. Trubino
"... .18 years, body mass index – 28.95±1.44 kg/m2. To evaluate lipid and carbohydrate metabolism blood chemistry ..."
 
Vol 6, No 1 (2010) EFFICACY OF PHYSICAL TRAINING AND ANALYSIS OF LIPID-LOWERING THERAPY IN PATIENTS WITH ISCHEMIC HEART DISEASE AFTER ACUTE CORONARY INCIDENTS Abstract  PDF (Eng)  similar documents
D. M. Aronov, V. B. Krasnitskij, M. G. Bubnova
"... Aim. To study efficacy of moderate-intensity physical training (PT) and evaluate lipid-lowering ..."
 
Vol 13, No 4 (2017) GENETIC PREDICTORS OF INTENSIVE LIPID-LOWERING THERAPY EFFICACY AND ITS ANTI-INFLAMMATORY EFFECTS IN VERY HIGH CARDIOVASCULAR RISK PATIENTS Abstract  similar documents
M. A. Vorobyeva, M. M. Azova, O. O. Gigani, I. V. Garmash, S. V. Villevalde, Zh. D. Kobalava
"... Aim. To study the anti-inflammatory effects of intensive lipid-lowering therapy and genetic ..."
 
Vol 11, No 1 (2015) ASPECTS OF LIPID-LOWERING THERAPY WITH ATORVASTATIN IN PATIENTS WITH MYOCARDIAL INFARCTION FROM THE PERSPECTIVE OF PERSONALIZED MEDICINE Abstract  similar documents
M. V. Solodun, S. S. Yakushin
"... . All patients were prescribed atorvastatin. A group of 65 people in whom lipid levels were studied ..."
 
Vol 4, No 1 (2008) ACHIEVEMENT OF LIPID TARGET PLASMA LEVELS IN PATIENTS OF HIGH CARDIOVASCULAR RISK: IS MEDICINE CHOICE IMPORTANT? Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko
 
Vol 19, No 6 (2023) New possibilities for lipid level control using inclisiran — prospects for interaction between a cardiologist and a neurologist Abstract  similar documents
A. B. Skiba, M. V. Menzorov, V. D. Puchek, I. M. Buchin, I. I. Polyakov, E. N. Menzorova
"... in the modern paradigm for dyslipidemia treatment from high-intensity statin therapy to high-intensity lipid ..."
 
Vol 6, No 4 (2010) EFFICACY OF VARIOUS DRUG FORMS OF LYCOPENE IN PATIENTS WITH DYSLIPIDEMIA Abstract  similar documents
P. Ya. Dovgalevsky, V. A. Klochkov, N. E. Chalyk, O. M. Ansimova, I. Petyaev
"... and high level of lipid peroxygenation (LPO). At the second step two groups of patients (n=28 and 31 ..."
 
1 - 100 of 293 Items 1 2 3 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)